---
figid: PMC5143492__npp2016167f3
figtitle: Neurotransmitter targets for therapeutic development in psychiatric disorders
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC5143492
filename: npp2016167f3.jpg
figlink: /pmc/articles/PMC5143492/figure/fig3/
number: F3
caption: 'Neurotransmitter targets for therapeutic development in psychiatric disorders.
  Aside from the more obvious immune targets of therapeutic interventions (eg, cytokines
  and their receptors, adhesion molecules, and chemokines), there are a host of metabolic
  and immunologic signaling pathways that mediate the downstream effects of inflammation
  on neurotransmitter systems including the synthesis, reuptake and release of dopamine,
  glutamate, and serotonin. Moreover, there is increasing interest in the role of
  the kynurenine pathway in multiple aspects of the impact of inflammation on excitotoxicity
  and neurotransmitter metabolism. 5HT: serotonin; 5HTT: serotonin transporter; BH4:
  tetrahydrobiopterin; DA: dopamine; EAAT: excitatory amino acid transporter; Glu:
  glutamate; IDO: indoleamine 2,3 dioxygenase; IL: interleukin; KA: kynurenic acid;
  KAT: kynurenine aminotransferase; KMO: kynurenine 3-monooxygenase; KYN: kynurenine;
  MAPK: mitogen-activated protein kinase; nAChR: nicotinic acetylcholine receptor;
  NF-κB: nuclear factor-κB; NMDAR: N-methyl-D-aspartate receptor; Phe: phenylalanine;
  QA: quinolinic acid; TH: tyrosine hydroxylase; TNF: tumor necrosis factor; TRP:
  tryptophan; Tyr: tyrosine.'
papertitle: 'Therapeutic Implications of Brain–Immune Interactions: Treatment in Translation.'
reftext: Andrew H Miller, et al. Neuropsychopharmacology. 2017 Jan;42(1):334-359.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.964041
figid_alias: PMC5143492__F3
figtype: Figure
redirect_from: /figures/PMC5143492__F3
ndex: cebc044b-ded5-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5143492__npp2016167f3.html
  '@type': Dataset
  description: 'Neurotransmitter targets for therapeutic development in psychiatric
    disorders. Aside from the more obvious immune targets of therapeutic interventions
    (eg, cytokines and their receptors, adhesion molecules, and chemokines), there
    are a host of metabolic and immunologic signaling pathways that mediate the downstream
    effects of inflammation on neurotransmitter systems including the synthesis, reuptake
    and release of dopamine, glutamate, and serotonin. Moreover, there is increasing
    interest in the role of the kynurenine pathway in multiple aspects of the impact
    of inflammation on excitotoxicity and neurotransmitter metabolism. 5HT: serotonin;
    5HTT: serotonin transporter; BH4: tetrahydrobiopterin; DA: dopamine; EAAT: excitatory
    amino acid transporter; Glu: glutamate; IDO: indoleamine 2,3 dioxygenase; IL:
    interleukin; KA: kynurenic acid; KAT: kynurenine aminotransferase; KMO: kynurenine
    3-monooxygenase; KYN: kynurenine; MAPK: mitogen-activated protein kinase; nAChR:
    nicotinic acetylcholine receptor; NF-κB: nuclear factor-κB; NMDAR: N-methyl-D-aspartate
    receptor; Phe: phenylalanine; QA: quinolinic acid; TH: tyrosine hydroxylase; TNF:
    tumor necrosis factor; TRP: tryptophan; Tyr: tyrosine.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Nmdar2
  - Nmdar1
  - da
  - nAChRalpha2
  - Dif
  - dl
  - Rel
  - cn
  - Gcn5
  - 5-HT1B
  - 5-HT1A
  - 5-HT2A
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - AIMP2
  - p38a
  - Hrb87F
  - p38c
  - MKP-4
  - rl
  - GRIN1
  - GRIN2A
  - GRIN2B
  - GRIN2C
  - GRIN2D
  - GRIN3A
  - GRIN3B
  - NFKB1
  - KMO
  - KATNB1
  - F11R
  - TSTD1
  - IDO1
  - CRK
  - MAPK14
  - MAPK1
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK3
  - MAPK8
  - MAPK9
  - MAPK10
---
